0
ARTICLE |

Topical Fluorouracil: Title and subTitle BreakII. Postoperative Administration in an Animal Model of Glaucoma Filtering Surgery FREE

Dale K. Heuer, MD; Michael G. Gressel, MD; Richard K. Parrish, II, MD; Robert Folberg, MD; John E. Dillberger, DVM; Norman H. Altman, VMD
[+] Author Affiliations

Accepted for publication Aug 23, 1985.

Reprint requests to Department of Ophthalmology, University of Florida College of Medicine, Box J-284, J. Hillis Miller Health Center, Gainesville, FL 32610 (Dr Heuer).


Arch Ophthalmol. 1986;104(1):132-136. doi:10.1001/archopht.1986.01050130146041
Text Size: A A A
Published online

• Unilateral posterior lip sclerectomies were performed in ten owl monkeys. Five milligrams of fluorouracil was injected subconjunctivally in each operated eye immediately after surgery. Three drops (approximately 2.4 mg/drop) of fluorouracil were instilled ten minutes apart in each operated eye twice daily on postoperative days 1 through 7 and once daily on postoperative days 8 through 15, 17, 19, and 21. One monkey died on the seventh postoperative day; its death could not be attributed to systemic fluorouracil toxicity. All of the operated eyes had filtering blebs after the full course of fluorouracil, but seven also had corneal epithelial defects. By the seventh postoperative week, two of the operated eyes manifested moderately severe corneal opacification. Ten weeks postoperatively, the electroretinographic a- and b-wave amplitudes averaged 17% and 12% less, respectively, in the seven operated eyes without clinically significant corneal opacification than in the unoperated fellow eyes. Only two eyes had blebs after the 12th postoperative week. Histopathologic examination was performed on five eyes, of which only two revealed patent sclerostomies. Although topical fluorouracil appears to delay bleb scarring, the corneal findings suggest that it may be more toxic than subconjunctival fluorouracil.

REFERENCES

Gressel MG, Parrish RK II, Folberg F:  5-Fluorouracil and glaucoma filtering surgery: I. An animal model . Ophthalmology 1984;;91:378-383.
Heuer DK, Parrish RK II, Gressel MG, et al:  5-Fluorouracil and glaucoma filtering surgery: II. A pilot study . Ophthalmology 1984;;91:384-393.
Rootman J, Tisdall J, Gudauskas G, et al:  Intraocular penetration of subconjunctivally administered 14C-fluorouracil in rabbits . Arch Ophthalmol 1979;;97:2375-2378.
Fantes FE, Heuer DK, Parrish RK II, et al:  Topical fluorouracil: Pharmacokinetics in normal rabbit eyes . Arch Ophthalmol 1985;;103:953-955.
Blumenkranz M, Hernandez E, Ophir A, et al:  5-Fluorouracil: New applications in complicated retinal detachment for an established antimetabolite . Ophthalmology 1984;;91:122-130.
Heuer DK, Fantes FE, Gressel MG, et al: Topical 5-fluorouracil: Pharmacokinetics, toxicity, and an animal model of glaucoma filtering surgery. Read before the 20th Annual Residents' Days, Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Miami, June 23, 1984.
Shapiro MS, Thoft RA, Friend J, et al:  5-Fluorouracil toxicity to the ocular surface epithelium . Invest Ophthalmol Vis Sci 1985;;26:580-583.
Blumenkranz M, Ophir A, Claflin A:  A pharmacologic approach to non-neoplastic intraocular proliferation , abstracted. Invest Ophthalmol Vis Sci 1981;;20(ARVO suppl):200.
Stern WH, Guerin CJ, Erickson PA, et al:  Ocular toxicity of fluorouracil after vitrectomy . Am J Ophthalmol 1983;;96:43-51.
Nao-i N, Honda Y:  Toxic effect of fluorouracil on the rabbit retina . Am J Ophthalmol 1983;;96:641-643.
Hamersley J, Luce JK, Florentz TR, et al:  Excessive lacrimation from fluorouracil treatment . JAMA 1973;;225:747-748.
Christophidis N, Lucas I, Vajda FJE, et al:  Lacrimation and 5-fluorouracil . Ann Intern Med 1978;;89:574.
Haidak DJ, Hurwitz BS, Yeung KY:  Tearduct fibrosis (dacryostenosis) due to 5-fluorouracil . Ann Intern Med 1978;;88:657.
Caravella LP Jr, Burns JA, Zangmeister M:  Punctal-canalicular stenosis related to systemic fluorouracil therapy . Arch Ophthalmol 1981;; 99:284-286.
Straus DJ, Mausolf FA, Ellerby RA, et al:  Cicatricial ectropion secondary to 5-fluorouracil therapy . Med Pediatr Oncol 1977;;3:15-19.
Parrish RK II, Heuer DK, Folberg R, et al:  Clinicopathologic correlation of the natural history of wound healing after filtering surgery in the owl monkey , abstracted. Invest Ophthalmol Vis Sci 1985;;26(ARVO suppl):125.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Gressel MG, Parrish RK II, Folberg F:  5-Fluorouracil and glaucoma filtering surgery: I. An animal model . Ophthalmology 1984;;91:378-383.
Heuer DK, Parrish RK II, Gressel MG, et al:  5-Fluorouracil and glaucoma filtering surgery: II. A pilot study . Ophthalmology 1984;;91:384-393.
Rootman J, Tisdall J, Gudauskas G, et al:  Intraocular penetration of subconjunctivally administered 14C-fluorouracil in rabbits . Arch Ophthalmol 1979;;97:2375-2378.
Fantes FE, Heuer DK, Parrish RK II, et al:  Topical fluorouracil: Pharmacokinetics in normal rabbit eyes . Arch Ophthalmol 1985;;103:953-955.
Blumenkranz M, Hernandez E, Ophir A, et al:  5-Fluorouracil: New applications in complicated retinal detachment for an established antimetabolite . Ophthalmology 1984;;91:122-130.
Heuer DK, Fantes FE, Gressel MG, et al: Topical 5-fluorouracil: Pharmacokinetics, toxicity, and an animal model of glaucoma filtering surgery. Read before the 20th Annual Residents' Days, Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Miami, June 23, 1984.
Shapiro MS, Thoft RA, Friend J, et al:  5-Fluorouracil toxicity to the ocular surface epithelium . Invest Ophthalmol Vis Sci 1985;;26:580-583.
Blumenkranz M, Ophir A, Claflin A:  A pharmacologic approach to non-neoplastic intraocular proliferation , abstracted. Invest Ophthalmol Vis Sci 1981;;20(ARVO suppl):200.
Stern WH, Guerin CJ, Erickson PA, et al:  Ocular toxicity of fluorouracil after vitrectomy . Am J Ophthalmol 1983;;96:43-51.
Nao-i N, Honda Y:  Toxic effect of fluorouracil on the rabbit retina . Am J Ophthalmol 1983;;96:641-643.
Hamersley J, Luce JK, Florentz TR, et al:  Excessive lacrimation from fluorouracil treatment . JAMA 1973;;225:747-748.
Christophidis N, Lucas I, Vajda FJE, et al:  Lacrimation and 5-fluorouracil . Ann Intern Med 1978;;89:574.
Haidak DJ, Hurwitz BS, Yeung KY:  Tearduct fibrosis (dacryostenosis) due to 5-fluorouracil . Ann Intern Med 1978;;88:657.
Caravella LP Jr, Burns JA, Zangmeister M:  Punctal-canalicular stenosis related to systemic fluorouracil therapy . Arch Ophthalmol 1981;; 99:284-286.
Straus DJ, Mausolf FA, Ellerby RA, et al:  Cicatricial ectropion secondary to 5-fluorouracil therapy . Med Pediatr Oncol 1977;;3:15-19.
Parrish RK II, Heuer DK, Folberg R, et al:  Clinicopathologic correlation of the natural history of wound healing after filtering surgery in the owl monkey , abstracted. Invest Ophthalmol Vis Sci 1985;;26(ARVO suppl):125.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.